AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Down 0.1% – Time to Sell?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was down 0.1% during trading on Friday . The stock traded as low as $11.42 and last traded at $11.49. Approximately 638,725 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 874,280 shares. The stock had previously closed at $11.50.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

The company’s 50 day moving average is $12.37 and its 200 day moving average is $13.56. The stock has a market cap of $295.29 million, a price-to-earnings ratio of 17.67 and a beta of -0.63.

Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Triumph Capital Management acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the third quarter worth about $70,000. J.Safra Asset Management Corp raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 10.0% during the fourth quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock worth $117,000 after acquiring an additional 741 shares during the last quarter. IFP Advisors Inc raised its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 7.4% in the third quarter. IFP Advisors Inc now owns 22,864 shares of the company’s stock valued at $364,000 after buying an additional 1,582 shares during the last quarter. Worth Asset Management LLC acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the fourth quarter valued at approximately $364,000. Finally, Bank of New York Mellon Corp raised its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after buying an additional 10,146 shares during the last quarter.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.